Comparison of Presentation and Management in Skeletal and Extraskeletal Ewing Sarcoma in Children
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70153 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Charbel Chidiac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Bone Neoplasms, Soft Tissue Neoplasms. Die Arbeit nennt 31 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Extraskeletal Ewing sarcoma (EES) is a variant of Ewing sarcoma that originates from soft tissues rather than bones. Our study aims to characterize the differences between EES and skeletal ES (SES) in the pediatric population.
Methods
We conducted a retrospective review of children ≤ 18 years with ES recorded in the National Cancer Data Base (NCDB) from 2004 to 2022. Kaplan−Meier curves and Cox proportional hazards regression analysis were used to identify risk factors associated with survival.
Results
Among 7446 identified patients, 1016 (20.9%) had EES and 6430 (79.1%) had SES. EES patients were older (median 14 vs. 13 years, p = 0.007), more often female (46.9% vs. 41.2%, p = 0.0009), and had smaller tumors (7.5 vs. 8.0 cm, p = 0.003). Tumor distribution differed significantly, with EES was most frequent in the thorax (49.8%) and head and neck (11.8%), while SES more common in the lower limbs (30.2%) and pelvis (25.3%) ( p < 0.0001). EES patients were more likely to receive surgery alone (4.2% vs. 1.8%) or a combination of surgery, chemotherapy, and radiation (25.9% vs. 20.7%) but less likely to receive chemotherapy and radiation without surgery (19.4% vs. 29.3%, p < 0.05). Five‐year overall survival was similar between SES (72.2%) and EES (73.7%) ( p = 0.70). Multivariable analysis confirmed EES was not an independent predictor of survival (aHR 0.94; 95% CI 0.81−1.10). Factors independently associated with mortality were older age, metastasis at diagnosis, and positive surgical margins.
Conclusions
Demographic, treatment characteristics, and prognostic factors differ between pediatric patients with SES and EES. However, survival is similar between the two groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Krieger School of Arts and Science, The Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Orthopedic Surgery, Division of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Oncology, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Charbel Chidiac, Daniel S Rhee
Zitieren
APA
Chidiac, C., Ramdat, C., McDermott, K. M., Levin, A. S., Lemberg, K. M., & Rhee, D. S. (2025). Comparison of Presentation and Management in Skeletal and Extraskeletal Ewing Sarcoma in Children. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70153
Vancouver
Chidiac C, Ramdat C, McDermott KM, Levin AS, Lemberg KM, Rhee DS. Comparison of Presentation and Management in Skeletal and Extraskeletal Ewing Sarcoma in Children. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70153
BibTeX
@article{Chidiac2025,
author = {Chidiac, Charbel and Ramdat, Caitlyn and McDermott, Katherine M and Levin, Adam S and Lemberg, Kathryn M and Rhee, Daniel S},
title = {Comparison of Presentation and Management in Skeletal and Extraskeletal Ewing Sarcoma in Children},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70153}
}
EUVIMED